Medicine information
Uses & overview
GLIEMPAFLOZIN SITA 25/100 Tablets is a combination antidiabetic medicine from Steris Healthcare, formulated with Empagliflozin 25 mg and Sitagliptin 100 mg. It is intended for the management of type 2 diabetes mellitus in adults when prescribed by a qualified healthcare professional. Composition: Empagliflozin IP – 25 mg Sitagliptin IP – 100 mg Key Benefits and Uses: Helps manage blood glucose levels in adults with type 2 diabetes mellitus. Empagliflozin helps the kidneys eliminate excess glucose through urine. Sitagliptin helps regulate blood glucose by enhancing incretin hormone activity and supporting glucose-dependent insulin release. Combines two complementary mechanisms to support glycemic control. Can complement a balanced diet and regular physical activity as advised by a healthcare professional. Product Features: GLIEMPAFLOZIN SITA 25/100 by Steris Healthcare combines Empagliflozin 25 mg and Sitagliptin 100 mg in one tablet for convenient, physician-directed diabetes management. Treatment suitability depends on individual blood glucose levels, kidney function, other medical conditions and concurrent medications. This medicine is intended for type 2 diabetes management and is not indicated for treating type 1 diabetes or diabetic ketoacidosis. It should be used only under medical supervision.
How to use
Take GLIEMPAFLOZIN SITA 25/100 Tablets exactly as prescribed by your physician. Follow the recommended dosage and timing, and swallow the tablet with water. Do not change the dose or discontinue treatment without medical advice. Your doctor may monitor blood glucose levels and kidney function during treatment.
Storage
Store GLIEMPAFLOZIN SITA 25/100 Tablets in a cool, dry place, away from direct sunlight and moisture. Keep the tablets in their original packaging and follow the storage instructions printed on the product label. Keep out of reach of children. Do not use after the expiry date.
